Compare RLMD & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLMD | ALCO |
|---|---|---|
| Founded | 2004 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 267.7M |
| IPO Year | 2012 | 1994 |
| Metric | RLMD | ALCO |
|---|---|---|
| Price | $4.48 | $40.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.25 | N/A |
| AVG Volume (30 Days) | ★ 545.8K | 21.3K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.50% |
| EPS Growth | ★ 19.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.24 | $27.02 |
| 52 Week High | $5.12 | $43.20 |
| Indicator | RLMD | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 46.77 |
| Support Level | $3.49 | $39.99 |
| Resistance Level | $4.56 | $41.96 |
| Average True Range (ATR) | 0.37 | 1.09 |
| MACD | 0.04 | -0.24 |
| Stochastic Oscillator | 70.89 | 37.68 |
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.